Monte Rosa Therapeutics, Inc. · NASDAQ:GLUE

Versant Venture Capital VI, L.P. reported a 5.10% stake in Monte Rosa Therapeutics, Inc. (Schedule 13D/A)

Event Nov 10, 2025 · Filed Nov 12, 2025

Versant Venture Capital VI, L.P. reported a 5.10% stake in Monte Rosa Therapeutics, Inc., 3,334,669 shares, with active intent on Nov 10, 2025. Filed Nov 12, 2025 (Schedule 13D/A).

Stake
5.10%
Shares
3,334,669
Intent
Active
What changed
Stake changed
Filed together
6 holders

The filing in full

HolderStakeShares
Versant Venture Capital VI, L.P.5.10%3,334,669
Versant Ventures VI GP, L.P.5.10%3,334,669
Versant Ventures VI GP-GP, LLC5.10%3,334,669
Versant Vantage I, L.P.2.40%1,573,453
Versant Vantage I GP, L.P.2.40%1,573,453
Versant Vantage I GP-GP, LLC2.40%1,573,453

Source

View original at SEC

Related